The prices of Gilead Sciences Inc. (GILD) shares have declined to $62.95 on April 19, which is only 4.2% above the three-year low of $60.32.

Gilead Sciences Inc. is an American international pharmaceutical and biotechnology company that develops and commercializes therapeutics. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C and influenza. Some of the products that the company developed include AmBisome, Atripla,

The prices of Macerich Co. (MAC) shares have declined to $52.72 on Sept. 22, which is only 1.1% above the 3-year low of $52.12.

Macerich Co. is an American self-managed real estate investment trust. It is the third-largest owner and operator of shopping centers in the United States, operating as a S&P 500 component. The company owns property across the United States, including property in California, Arizona, Washington, Missouri, and New York.

Current profit drop should not worry investors, but balance sheet status probably should

Macerich (MAC), the $7.76 billion California-based real estate investment trust (REIT), reported a (-)4.2% year-over-year revenue decline to $494.5 million and a far worse (-)79.4% drop in profits to $95.88 million in the second quarter resulting in a 19% margin compared to 90% a year earlier.

The REIT registered a (-)2.3% decline in expenses but what brought the profits into a tailspin was the nearly $470 million gains the company had a year earlier after it sold several interests in its portfolio to other parties (1).

Excluding all these gains in both periods, Macerich would have delivered (-)1.2% decline in

The prices of Macerich Co (MAC) shares have declined to $57.85 on July 28, which is only 3.1% above the 3-year low of $56.06.

Macerich Co is an American self-managed real estate investment trust. It is the third-largest owner and operator of shopping centers in the United States, operating as a S&P 500 component. The company owns property across the United States, including property in California, Arizona, Washington, Missouri, and New

The prices of Alexion Pharmaceuticals Inc. (ALXN) shares have declined to $113.84 on May 19, which is only 4.1% above the three-year low of $109.12.

Alexion Pharmaceuticals Inc is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria. The company is also involved in immune system research that focuses on autoimmune diseases.

The prices of DDR Corp (DDR) shares have declined to $12.53, which is only 1.3% above the 3-year low of $12.37.

DDR Corp is an American real estate investment trust company that owns and manages value-oriented open air retail shopping centers in the United States and Puerto Rico. Tenants include Wal-Mart, Kohl’s, PetSmart, and Michaels. It operates in 40 continental U.S. states and Puerto Rico.

We are pleased to provide you with the Third Avenue Real Estate Value Fund’s (Fund) report for the quarter ended October 31, 2015.

Quarterly Activity

The Fund’s fiscal fourth quarter marked one of the most active periods in its seventeen year history. In fact, the recent activity wraps up one of the Fund’s most transformative years, as cash balances were reduced from more than 20% early in the year to nearly 7% once factoring in anticipated investments (see Trinity Place Holdings discussion below). The bulk of the activity included: initiating positions in a select set of new

The largest new investment during the year was the common stock of the Macerich Company (Macerich). Macerich (MAC) is a US REIT (Real Estate Investment Trust) that owns the fourth most valuable mall portfolio in North America with a particular concentration of market dominant malls in key East Coast markets (e.g., New York City, Washington, D.C.) as well as one of the strongest positions on the West Coast (e.g., California, Arizona, Oregon). Nearly a year ago, Simon Property Group—the largest mall owner globally—purchased a 4% stake in Macerich and launched a bid to buy the entire company for $96 per

Third Avenue Management (Trades, Portfolio)’s most significant transaction of the second quarter was its addition of 1,087,200 shares to its stake in Macerich Co. (MAC), a Santa Monica, Calif.-based Real Estate Investment

The All-In-One Guru Screenercan be used to find out the most insider buys over the last week by clicking on the insiders tab and changing the settings for All Insider Buying “$5,000,000+” and Duration to "over the past 7 days."

Trades by insiders of the past 7 days, according to the above filters are about Macerich Co (MAC) and Seattle Genetics Inc (SGEN):

On May 19, Ontario teachers pension plan which is director and 10% owner of Macerich Co (MAC) paid $98,698,900 to buy 1,186,000 shares

A deal that could bring together two of the largest mall operators in the United States just took a new, seemingly dead-end, turn. Simon Property Group Inc. (SPG) raised its earlier offer of $91 per share by 5% to $95.50 per share for Macerich Co. (MAC) bringing the value of the deal to $16.8 billion. But the "sweeter" deal comes with both a rider, as well as a tight deadline within which Macerich is expected to respond to the new offer. The largest mall owner in the country declared the offer for its second-in-line rival as "final". Simon Property has

Last Friday Simon Properties Group (SPG) announced that it just made its best an final offer for rival Macerich (MAC) and boosted its bid by 4.9% to $95.50 per share. The new cash and stock offer values Macerich at $16.8 billion not including debt. Simon Properties first bid was rejected outright by Macerich for being to low. The first offer was $91 per share in cash and stock deal which Macerich board said undervalued the company.

After Macerich rejected Simons first bid, its CEO David Simon said, "Macerich’s decision to adopt extreme defensive measures is disappointing.”

The Macerich Company (MAC) is a self-administered and self-managed real estate investment trust (REIT). The company is involved in the acquisition, ownership, development, redevelopment, management and leasing of regional and community shopping centers located throughout the U.S.

So let's take a look at this company and try to explain to investors the reasons I would stay away from this stock.

Online Shopping

There is a significant rise in online shopping through the Internet mobile phones and tablets. This affected the demand in a negative way as well as increased competition. The recent lucrative deal with Deliv is expected to offset

GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser.
Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security.
The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations.
The gurus may buy and sell securities before and after any particular article and report and information herein is published,
with respect to the securities discussed in any article and report posted herein. In no event shall
GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other
material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including,
without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages.
Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters,
is not intended to be, nor does it constitute, investment advice or recommendations.
The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website
are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data.
Fundamental company data provided by Morningstar, updated daily.